Načítá se...
Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application
The heart is one of the organs most vulnerable to sepsis. This review describes the general characteristics of sepsis-induced cardiomyopathy and the main pathogenesis of myocardial dysfunction in sepsis. Levosimendan is a novel drug for treatment of sepsis-induced myocardial dysfunction. This review...
Uloženo v:
| Vydáno v: | J Int Med Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6567749/ https://ncbi.nlm.nih.gov/pubmed/30958071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519837103 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|